Lauro Amezcua-Patino
Psychiatry · Maywood, ILNPI 1659364396
Payments from drug & device makers
What this record shows
Sunovion Pharmaceuticals Inc. accounts for 89.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2020 at $765 and has fallen 92.4% since, to $58 in 2022.
Across 46 payments — averaging $32.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$1K
- AbbVie$49
- Alkermes, Inc.$42
- Johnson & Johnson$40
- Otsuka America Pharmaceutical, Inc.$21
Across 86 payments — averaging $5595.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Supernus Pharmaceuticals, Inc.$275K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$70K
- Orexo US, Inc.$56K
- Alkermes, Inc.$53K
- Biohaven Pharmaceuticals, Inc.$16K
- Biohaven Pharmaceutical Holding Company Ltd.$11K
- plus $1K from 1 others
What the payments were for
- Speaking & faculty fees$88560%
- Food & beverage$59540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 38 | $1,327 |
| AbbVie | 3 | $49 |
| Alkermes, Inc. | 2 | $42 |
| Johnson & Johnson | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LATUDA$885
How this compares
$1,480 in reported general payments places this provider in the 80th percentile of 1,344 psychiatry providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 14 | $11,016 |
| Trazodone Hcl | 47 | $768 |
| Alprazolam | 64 | $760 |
| Bupropion XlBupropion Hcl | 19 | $694 |
| Duloxetine Hcl | 19 | $626 |
| Lamotrigine | 35 | $613 |
| Clonazepam | 51 | $555 |
| Escitalopram Oxalate | 31 | $421 |
| Gabapentin | 17 | $331 |
| Fluoxetine Hcl | 15 | $311 |
| Olanzapine | 17 | $286 |
| Sertraline Hcl | 17 | $244 |
| Quetiapine Fumarate | 23 | $238 |
| Guanfacine Hcl | 15 | $221 |
| Mirtazapine | 16 | $216 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Maywood
- Angelos HalarisMaywood$94K
- Michael FeldNorthbrook$1.1M
- Jose MontesRockford$882K
- Mitchell GlaserChicago$752K
- Roukan JazayerliOrland Park$597K
- Ming XuBourbonnais$505K
- Peter WeidenChicago$440K
- Michelle DeesChicago$289K
- Mark ShukhmanSkokie$250K
- Abid NazeerOak Brook$228K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.